Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium - PubMed (original) (raw)
Comparative Study
. 2006 Mar;6(6):1989-2002.
doi: 10.1002/pmic.200500129.
Affiliations
- PMID: 16470630
- DOI: 10.1002/pmic.200500129
Comparative Study
Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium
Gernot Hudelist et al. Proteomics. 2006 Mar.
Abstract
Gene expression analysis has become a promising tool in predicting the clinical course of malignant disease and the response to antineoplastic therapy. Surprisingly, only little is known about the protein expression pattern of human tumors. Recent advances in proteomic analysis allow proteins of interest to be identified by their expression and/or modification pattern in 2-DE rather than using the traditional approach of translating gene expression data. To identify a proteomic pattern that is characteristic for malignant breast epithelium, we performed differential 2-DE analysis in sets of microdissected malignant breast epithelia and corresponding adjacent normal breast epithelia from five patients with invasive breast carcinoma. Thirty-two protein spots were found to be selectively regulated in malignant epithelium, and were subjected to MALDI-TOF and/or immunoblotting for protein identification. Thirteen of the identified proteins had previously not been associated with breast cancer. The validity of these findings was confirmed by literature review and immunohistochemistry for identified proteins in an independent cohort of 50 breast cancer specimens. We here describe, for the first time, a proteomic analysis of matched normal and malignant epithelia from invasive breast carcinomas. This strategy leads to a better understanding of oncogenesis at an operational level and helps to characterize the malignant phenotype of individual tumors, and thereby to identify novel targets for antineoplastic therapy.
Similar articles
- Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G, Charbonnel C, Lodé L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Déporte-Fety R, Campion L, Jézéquel P. Ricolleau G, et al. Proteomics. 2006 Mar;6(6):1963-75. doi: 10.1002/pmic.200500283. Proteomics. 2006. PMID: 16470659 - Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z, Jian-Guo J, Yuan-Peng T, Hai P, Bing-Gen R. Rui Z, et al. Proteomics. 2003 Apr;3(4):433-9. doi: 10.1002/pmic.200390058. Proteomics. 2003. PMID: 12687611 - Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
Zhang DH, Tai LK, Wong LL, Sethi SK, Koay ES. Zhang DH, et al. Proteomics. 2005 May;5(7):1797-805. doi: 10.1002/pmic.200401069. Proteomics. 2005. PMID: 15825149 - Proteomics of breast carcinoma.
Somiari RI, Somiari S, Russell S, Shriver CD. Somiari RI, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):215-25. doi: 10.1016/j.jchromb.2004.11.012. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15652811 Review. - Clinical proteomics in breast cancer: a review.
Gast MC, Schellens JH, Beijnen JH. Gast MC, et al. Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review.
Cited by
- A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer Progression.
Streckfus CF, Bigler L. Streckfus CF, et al. Sci Rep. 2016 Aug 1;6:30800. doi: 10.1038/srep30800. Sci Rep. 2016. PMID: 27477923 Free PMC article. Clinical Trial. - Breast tumor metastasis: analysis via proteomic profiling.
Goodison S, Urquidi V. Goodison S, et al. Expert Rev Proteomics. 2008 Jun;5(3):457-67. doi: 10.1586/14789450.5.3.457. Expert Rev Proteomics. 2008. PMID: 18532913 Free PMC article. Review. - Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.
Umar A, Kang H, Timmermans AM, Look MP, Meijer-van Gelder ME, den Bakker MA, Jaitly N, Martens JW, Luider TM, Foekens JA, Pasa-Tolić L. Umar A, et al. Mol Cell Proteomics. 2009 Jun;8(6):1278-94. doi: 10.1074/mcp.M800493-MCP200. Epub 2009 Mar 27. Mol Cell Proteomics. 2009. PMID: 19329653 Free PMC article. - Proteomic analysis of haptoglobin and amyloid A protein levels in patients with vivax malaria.
Bahk YY, Na BK, Cho SH, Kim JY, Lim KJ, Kim TS. Bahk YY, et al. Korean J Parasitol. 2010 Sep;48(3):203-11. doi: 10.3347/kjp.2010.48.3.203. Epub 2010 Sep 16. Korean J Parasitol. 2010. PMID: 20877498 Free PMC article. - Transforming Diagnosis and Therapeutics Using Cancer Genomics.
Mehmood S, Aslam S, Dilshad E, Ismail H, Khan AN. Mehmood S, et al. Cancer Treat Res. 2023;185:15-47. doi: 10.1007/978-3-031-27156-4_2. Cancer Treat Res. 2023. PMID: 37306902
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical